======= EPC1 =======
== Gene Information ==
* **Official Symbol**: EPC1
* **Official Name**: enhancer of polycomb homolog 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=80314|80314]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H2F5|Q9H2F5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=EPC1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EPC1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610999|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|E Pc C|
|EPL1|
|Piccolo NuA4 histone acetyltransferase complex|
|vascular smooth muscle cell differentiation|
|histone H2A acetylation|
|NuA4 histone acetyltransferase complex|
|smooth muscle cell differentiation|
|negative regulation of G0 to G1 transition|
|regulation of G0 to G1 transition|
|histone acetyltransferase activity|
|histone H4 acetylation|
|negative regulation of gene expression, epigenetic|
|histone acetylation|
|internal peptidyl-lysine acetylation|
|peptidyl-lysine acetylation|
|internal protein amino acid acetylation|
|protein acetylation|
|protein acylation|
|regulation of gene expression, epigenetic|
|nuclear membrane|
|muscle cell differentiation|
|peptidyl-lysine modification|
|negative regulation of cell cycle process|
|histone modification|
|covalent chromatin modification|
|muscle structure development|
|vasculature development|
|cardiovascular system development|
|negative regulation of cell cycle|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|regulation of growth|
|chromatin organization|
|regulation of cell cycle process|
|negative regulation of transcription by RNA polymerase II|
|circulatory system development|
|peptidyl-amino acid modification|
|chromosome organization|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|regulation of cell cycle|
|negative regulation of transcription, DNA-templated|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|organic cyclic compound biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|macromolecule biosynthetic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.43|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.09|
|[[:results:exp220|BAY-598 4μM R05 exp220]]|-1.71|
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.7|
|[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.74|
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.77|
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.79|
|[[:results:exp79|Q15 2.7μM R02 exp79]]|2.09|
|[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|2.26|
|[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.43|
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.65|
|[[:results:exp34|Rotenone 20μM R00 exp34]]|2.76|
^Gene^Correlation^
|[[:human genes:e:epc2|EPC2]]|0.479|
Global Fraction of Cell Lines Where Essential: 8/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|1/28|
|blood|0/28|
|bone|0/25|
|breast|1/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|1/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|1/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|2/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2941
* **Expression level (log2 read counts)**: 6.17
{{:chemogenomics:nalm6 dist.png?nolink |}}